A Phase 1B/2 trial of second line immunotherapy with pepinemab and avelumab for patients with metastatic pancreatic adenocarcinoma

被引：0
|
作者：
Ruffolo, Luis I.
Byrne, Matthew
Hilty, Bailey
Belt, Brian A.
Dave, Yatee
Burchard, Paul
Fisher, Terrence
Evans, Elizabeth E.
Mallow, Crystal
Boise, Megan
Carpizo, Darren
Yeh, Jen Jen
Linehan, David C.
Mulkerin, Daniel
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-A004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A004
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma.
    Ruffolo, Luis I.
    Fisher, Terrence Lee
    Evans, Elizabeth E.
    Mallow, Crystal L.
    Boise, Megan
    Foster, Amber
    Leonard, John E.
    Belt, Brian A.
    Yeh, Jen Jen
    Zauderer, Maurice
    Linehan, David
    Mulkerin, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.
    Hilty, Bailey
    Ruffolo, Luis I.
    Belt, Brian A.
    Byrne, Matthew
    Dave, Yatee A.
    Burchard, Paul R.
    Fisher, Terrence Lee
    Evans, Elizabeth E.
    Mallow, Crystal L.
    Boise, Megan
    Zauderer, Maurice
    Mulkerin, Daniel
    Yeh, Jen Jen
    Linehan, David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS712 - TPS712
  • [3] AVELUMAB plus BINIMETINIB IN METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC): DOSE-ESCALATION RESULTS FROM THE PHASE 1B/2 JAVELIN PARP MEKI TRIAL
    Rodon, Jordi
    Tan, Daniel Weng
    Laguna, Ignacio Garrido
    Harb, Wael
    Beck, J. Thaddeus
    Bahary, Nathan
    Rottey, Sylvie
    Zhu, Zhou
    Deng, Shibing
    Kowalski, Karen
    O'Neill, Grainne
    Wei, Caimiao
    Pathan, Nuzhat
    Messersmith, Wells
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A371 - A371
  • [4] A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma
    O'Neill, Conor
    Hayat, Traci
    Hamm, John
    Healey, Mary
    Zheng, Qianqian
    Li, Yan
    Martin, Robert C. G., II
    SURGERY, 2020, 168 (04) : 610 - 616
  • [5] Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
    Keilholz, Ulrich
    Mehnert, Janice M.
    Bauer, Sebastian
    Bourgeois, Hugues
    Patel, Manish R.
    Gravenor, Donald
    Nemunaitis, John J.
    Taylor, Matthew H.
    Wyrwicz, Lucjan
    Lee, Keun-Wook
    Kasturi, Vijay
    Chin, Kevin
    von Heydebreck, Anja
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial.
    Keilholz, Ulrich
    Mehnert, Janice M.
    Bauer, Sebastian
    Bourgeois, Hugues Pierre
    Patel, Manish R.
    Gravenor, Donald
    Nemunaitis, John J.
    Taylor, Matthew H.
    Wyrwicz, Lucjan
    Lee, Keun-Wook
    Kasturi, Vijay
    Chin, Kevin M.
    von Heydebreck, Anja
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [7] Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
    Le Tourneau, Christophe
    Hoimes, Christopher
    Zarwan, Corrine
    Wong, Deborah J.
    Bauer, Sebastian
    Claus, Rainer
    Wermke, Martin
    Hariharan, Subramanian
    von Heydebreck, Anja
    Kasturi, Vijay
    Chand, Vikram
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [8] A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
    Ng, Matthew
    Chen, Sylvia
    Ong, Whee Sze
    Balachander, Akhila
    Seet, Amanda
    Yeong, Joe
    Sutiman, Natalia
    Lim, Tony Kiat Hon
    Lee, Bernett
    Guo, Yu Amanda
    Leong, Wai Fook
    Lee, Sze Sing
    Lam, Justina
    Choo, Su Pin
    Skanderup, Anders Jacobsen
    Biswas, Subhra Kumar
    Tai, David
    Chowbay, Balram
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (03) : 435 - 449
  • [9] Avelumab in patients with metastatic urothelial carcinoma: Pooled results from two cohorts of the phase 1b JAVELIN Solid Tumor trial.
    Patel, Manish R.
    Ellerton, John Allan
    Infante, Jeffrey R.
    Agrawal, Manish
    Gordon, Michael S.
    Aljumaliy, Raid
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [10] Phase 1b/2 study results for masitinib plus irinotecan in second-line treatment of esophagogastric adenocarcinoma
    Zaanan, A.
    Bennouna, J.
    Hiret, S.
    Douillard, J. Y.
    Bouche, O.
    Tougeron, D.
    Lecomte, T.
    Ezenfis, J.
    Lepere, C.
    Mansfield, C.
    Moussy, A.
    Dubreuil, P.
    Hermine, O.
    Taieb, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S451 - S451
12345